Metraipolis › archive › dc_c490e65e4e6e

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE — Europe PMC PMID:42005909

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42005909
DOI
10.1016/j.xops.2026.101148
License (as archived)
solo-consultazione
Archived
2026-11-04T21:28:49.213Z
SHA-256 of the archived text
b1760366609b813d8812219e2db50b4d491b2463222d93a5556beb60cdbf7e07
Stable URL of this page
https://metraipolis.com/documento/dc_c490e65e4e6e

How to cite

Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE — Europe PMC PMID:42005909 — Europe PMC (en), https://europepmc.org/article/MED/42005909 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c490e65e4e6e (Metraipolis archive dc_c490e65e4e6e, sha256 b1760366609b813d8812219e2db50b4d491b2463222d93a5556beb60cdbf7e07)
BibTeX
@misc{dcc490e65e4e6e,
  title = {Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA/LUCERNE — Europe PMC PMID:42005909},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42005909},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c490e65e4e6e; sha256 b1760366609b813d8812219e2db50b4d491b2463222d93a5556beb60cdbf7e07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42005909. Agents can read the archived copy with the MCP tool read_document.